Clover Health Investments Corp.
BioSniper Score
Based on 4 of 6 signals
Market Cap
$2.63B
Cash Runway
1.1 mo
Lead Asset
bio-cybernetic cardio-diagnosis system
Next Catalyst
—
Tracking 8 pipeline candidates · 3 clinical trials for Clover Health Investments Corp. · Updated within the last hour.
Go deeper on Clover Health Investments Corp. with Spotter
Ask follow-up questions and run a full multi-agent deep dive on CLOV — live, with citations.
Score breakdownBased on 4 of 6 signals · derived from public data
1.1 months
D/E 1.06
No tracked pipeline phase
8 candidates
No upcoming catalysts tracked
0 buys · 7 sells (180d)
Key Financialsas of March 31, 2026
Cash
$173.3M
Quarterly Burn
$721.9M
Revenue
$749.2M
Free Cash Flow
$107.0M
Total Liabilities
$358.3M
Shareholders Equity
$339.4M
Current Ratio
1.33
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (8 candidates)
Commercialization & Governance
Commercialization
- Launch Markets
- United States
- Commercial Strategy
- The company utilizes a strategy centered on deploying its proprietary Clover Assistant software to primary care providers to improve clinical decision-making and manage chronic diseases. It operates Medicare Advantage plans and has launched Counterpart Health, Inc. to provide a SaaS and Tech-Enabled Services solution to external payors and providers.
Governance
- Board Size
- 9
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
209
Total value held
$261.5M
| Holder | Shares | Value |
|---|---|---|
| vanguard capital management llc | 33,964,146 | $59.8M |
| blackrock, inc. | 31,840,512 | $56.0M |
| geode capital management, llc | 10,055,510 | $17.7M |
| state street corp | 9,559,889 | $16.8M |
| charles schwab investment management inc | 5,300,475 | $9.3M |
| susquehanna international group, llp | 5,091,057 | $9.0M |
| pnc financial services group, inc. | 3,764,034 | $6.6M |
| vanguard portfolio management llc | 3,696,437 | $6.5M |
| dimensional fund advisors lp | 3,417,866 | $6.0M |
| renaissance technologies llc | 3,401,541 | $6.0M |
Showing top 10 of 209 institutional holders of Clover Health Investments Corp.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
Who is the CEO of Clover Health Investments Corp.?
Mr. Andrew Toy is the chief executive officer of Clover Health Investments Corp. (CLOV).
Where is Clover Health Investments Corp. headquartered?
Clover Health Investments Corp. (CLOV) is headquartered in Wilmington, DE, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.
Get the full picture on Clover Health Investments Corp.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.